Anorexia Nervosa Clinical Trials 2023

What are the top hospitals conducting anorexia nervosa research?

Anorexia nervosa, a complex and devastating eating disorder, is being tackled head-on by top hospitals across the United States. In sunny San Diego, the University of California San Diego leads the charge with seven ongoing clinical trials for anorexia nervosa. Since their first recorded trial in 2015, this institution has been committed to unraveling the complexities of this condition. Meanwhile, in Tulsa's Laureate Institute for Brain Research, cutting-edge research is taking place with four active anorexia nervosa trials and five completed studies since their inaugural trial in 2015.

Moving towards Louisville, Kentucky we find the Eating Anxiety Treatment Laboratory and Clinic where researchers are currently conducting three active clinical trials focused on anorexia nervosa. Despite being relatively new to this field compared to others on our list—having started their first trial only in 2016—they have already made significant strides toward understanding and treating this disorder.

In bustling New york City, the Department of Psychiatry's Eating and Weight Disorders Program is making its mark with two ongoing anorexia nervosa trials. Although they have conducted just two previous studies thus far since commencing their pioneering work in 2022; it highlights their commitment to exploring innovative approaches that could potentially revolutionize treatment methods.

Lastly but certainly not least, we turn our attention towards picturesque San Francisco at the University of California where impactful research unfolds concerning anorexia nervosa as well. With two current clinical trials and three all-time studies conducted since initiating investigations back in 2017; they continue adding valuable knowledge about this enigmatic illness.

These esteemed institutions signify hope for those affected by anorexia nervosa—a beacon illuminating a path towards better understanding and more effective treatments for individuals grappling with this mentally challenging disorder. The tireless efforts carried out within these progressive medical centers exemplify our collective dedication to combating anorexia nervosa while emphasizing that every stride forward brings us closer to a brighter future for individuals and families impacted by this condition.

Which are the best cities for anorexia nervosa clinical trials?

When it comes to anorexia nervosa clinical trials, certain cities emerge as leaders in research and treatment options. San Diego, California hosts 8 active trials focusing on various interventions such as behavioral therapies, cannabidiol, and psilocybin. New york City follows closely with 6 ongoing studies exploring treatments like vagal nerve stimulation (taVNS), SilverCloud Health mobile intervention, and high-frequency repetitive transcranial magnetic stimulation (HF-rTMS). Additionally, Louisville, Kentucky offers 4 active trials investigating approaches like facing eating disorder fears condition and imaginal exposure therapy. These cities provide individuals struggling with anorexia nervosa access to cutting-edge clinical trials that pave the way for improved care strategies and hope for recovery.

Which are the top treatments for anorexia nervosa being explored in clinical trials?

Clinical trials are paving the way for advancements in treating anorexia nervosa, with several promising options under investigation. Isoproterenol shows potential, currently being explored in two active trials and having a total of two all-time trials dedicated to anorexia nervosa since its listing in 2015. Olanzapine is another treatment option gaining attention, with two ongoing trials and a total of seven historical studies focused on anorexia nervosa since its introduction in 2000. Additionally, a novel approach called Facing Eating disorder Fears Condition has emerged as a contender, currently undergoing one active trial following its recent listing in 2022. These innovative treatments offer hope for individuals battling anorexia nervosa and may contribute to improved outcomes in the future.

What are the most recent clinical trials for anorexia nervosa?

Exciting advancements are being made in the field of anorexia nervosa treatment, with several recent clinical trials offering new hope for those affected by this challenging condition. One such trial is investigating the efficacy of ponsegromab, a potential therapeutic option currently in Phase 2 testing. Additionally, psilocybin has shown promise as a treatment modality in Phase 2 trials. Another avenue being explored is the use of naltrexone hydrochloride, which has progressed to both Phase 2 and Phase 3 studies. Lastly, olanzapine is also under investigation through separate Phase 2 and Phase 3 trials. These innovative approaches hold great potential for improving outcomes and quality of life for individuals living with anorexia nervosa.

What anorexia nervosa clinical trials were recently completed?

Recently, several clinical trials focused on anorexia nervosa have reached significant milestones, presenting new possibilities for the treatment of this complex eating disorder. In April 2021, Homeostasis Therapeutics successfully completed a trial investigating the effectiveness of Ketamine Hcl 50Mg/Ml Inj as a potential therapeutic option. Another notable study conducted by Johns Hopkins University investigated Psilocybin and its impact on anorexia nervosa; this trial concluded in August 2019. These recent advancements underline the ongoing efforts to develop innovative treatments that can offer hope and support for individuals struggling with anorexia nervosa.